Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.

Yokoyama Y, Lew ED, Seelige R, Tindall EA, Walsh C, Fagan PC, Lee JY, Nevarez R, Oh J, Tucker KD, Chen M, Diliberto A, Vaaler H, Smith KM, Albert A, Li G, Bui JD.

Cancer Res. 2019 Apr 15;79(8):1996-2008. doi: 10.1158/0008-5472.CAN-18-2022. Epub 2019 Feb 5.

PMID:
30723115
2.

Automated external defibrillator availability and CPR training among state police agencies in the United States.

Hirsch LM, Wallace SK, Leary M, Tucker KD, Becker LB, Abella BS.

Ann Emerg Med. 2012 Jul;60(1):57-62. doi: 10.1016/j.annemergmed.2011.11.034. Epub 2012 Jan 20.

PMID:
22261517
3.

Antifungal flavonoids from Hildegardia barteri.

Meragelman TL, Tucker KD, McCloud TG, Cardellina JH 2nd, Shoemaker RH.

J Nat Prod. 2005 Dec;68(12):1790-2.

PMID:
16378378
4.

Aspirochlorine class compounds from Aspergillus flavus inhibit azole-resistant Candida albicans.

Klausmeyer P, McCloud TG, Tucker KD, Cardellina JH 2nd, Shoemaker RH.

J Nat Prod. 2005 Aug;68(8):1300-2.

PMID:
16124785
5.

A novel antimicrobial indolizinium alkaloid from Aniba panurensis.

Klausmeyer P, Chmurny GN, McCloud TG, Tucker KD, Shoemaker RH.

J Nat Prod. 2004 Oct;67(10):1732-5.

PMID:
15497951
6.

Many chemokines including CCL20/MIP-3alpha display antimicrobial activity.

Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ.

J Leukoc Biol. 2003 Sep;74(3):448-55.

PMID:
12949249
7.
8.

Inactivated whole-cell bacterial vaccines: current status and novel strategies.

Pace JL, Rossi HA, Esposito VM, Frey SM, Tucker KD, Walker RI.

Vaccine. 1998 Oct;16(16):1563-74. Review.

PMID:
9711805
9.

Development of a Dietary Exposure Potential Model for evaluating dietary exposure to chemical residues in food.

Tomerlin JR, Berry MR, Tran NL, Chew SB, Petersen BJ, Tucker KD, Fleming KH.

J Expo Anal Environ Epidemiol. 1997 Jan-Mar;7(1):81-101.

PMID:
9076611
10.

Functional analysis of the Pseudomonas aeruginosa autoinducer PAI.

Passador L, Tucker KD, Guertin KR, Journet MP, Kende AS, Iglewski BH.

J Bacteriol. 1996 Oct;178(20):5995-6000.

11.

Structure-based design of novel, urea-containing FKBP12 inhibitors.

Dragovich PS, Barker JE, French J, Imbacuan M, Kalish VJ, Kissinger CR, Knighton DR, Lewis CT, Moomaw EW, Parge HE, Pelletier LA, Prins TJ, Showalter RE, Tatlock JH, Tucker KD, Villafranca JE.

J Med Chem. 1996 Apr 26;39(9):1872-84.

PMID:
8627611
12.

Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.

Kissinger CR, Parge HE, Knighton DR, Lewis CT, Pelletier LA, Tempczyk A, Kalish VJ, Tucker KD, Showalter RE, Moomaw EW, et al.

Nature. 1995 Dec 7;378(6557):641-4.

PMID:
8524402
13.

Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes.

Pearson JP, Gray KM, Passador L, Tucker KD, Eberhard A, Iglewski BH, Greenberg EP.

Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):197-201.

14.
15.

Toxin A of Clostridium difficile is a potent cytotoxin.

Tucker KD, Carrig PE, Wilkins TD.

J Clin Microbiol. 1990 May;28(5):869-71.

Supplemental Content

Loading ...
Support Center